Okada E.(2018), Knowledge corruption and governance in academic knowledge-intensive organizations: The case of
molecular mutations research, Journal of Public Affairs, 18(1).
Okada, E. (2015), The Third Annual Conference on Governance of Emerging Technologies: Law, Policy
and Ethics, Arizona State University Sandra Day O'Connor College of Law, May 26-28, 2015.
Okada, E. (2014, postponed to Sept. 2015), The International Multidiscipline Conference on Arts, Science and Technology, Boston, MA.
Okada, E. Working Paper No. 2017-3, Jul. 20, 2017
Okada, E. Working Paper No. 2017-2, May 31, 2017.
Okada, E. Working Paper No. 2017-1, Mar. 31, 2017
Okada, E. Working Paper No. 2016-3, Oct. 30 2016.
Okada. E. Working Paper No. 2016-2, Sept. 30 2016,
Okada, E. Working Paper No. 2016-01, Jan,.2016.
Okada, E., Working Paper No. 2015-01, Dec. 2015.
(i) Conduct social science research committed to National Academy of Medicine (2014) Recommendations.
Submitted a Statement of Commitment to Institute of Medicine (National Academy of Medicine):
Updated Statement of Research Commitment to National Academy of Medicine to Recommendations of Institute of Medicine (2014) in: Assessing Progress in End-of-Life and Serious Illness Care, National Academy of Medicine. 2016: 87-94.
(ii) Joined, as working group member, Post Trial Responsibility Working Group at Multi- Regional Clinical Trial Center of Harvard and Brigham and Women's Hospital.
The focus is ethics principles/ ethical frameworks.
Guidance Document version 1 was uploaded. See:
MRCT Center Post-Trial Responsibilities Framework
Continued Access to Investigational Medicines
Financial documents are available at Duns & Bradstreet (NY), and the Office of Attorney General, (MA).